Huawei Launches Medical Tech 2.0 Solution, An AI-Driven Digital Healthcare Solution For Better Treatment

At HUAWEI CONNECT 2024, Huawei, alongside its partners, introduced the Medical Technology Digitalization 2.0 Solution during the healthcare session titled "Enhancing Inclusivity to Amplify Healthcare Intelligence." This innovative solution leverages AI for assisted diagnosis and intelligent quality control, advancing precision healthcare and streamlining hierarchical diagnosis and treatment systems.

Key participants in the launch included Sun Pengfei, Vice President of Huawei Global Public Sector; Hou Yu, CEO and Founder of MED Imaging AI; Zhang Yu, General Manager of Wanxiang Medical Technology Co., Ltd.; Sun Fenglei, Product Strategy Director at Beijing DeepWise Technology Co., Ltd.; and Liu Zheng, Business Development Director of KFBIO.

Medical imaging constitutes the majority of clinical data, representing about 80%. With the integration of AI, the potential of this data is unlocked, playing a crucial role in diagnostics, treatment planning, and preventive care. Huawei's Medical Technology Digitalization 2.0 Solution combines AI, computing, storage, and networking to work alongside industry partners in enhancing healthcare. By leveraging AI-driven quality control and diagnostic tools, the solution optimizes both the accuracy and efficiency of medical services. This technology has already been adopted in facilities such as the Fourth People's Hospital of Shenyang.

This advanced medical imaging solution leverages AI to accurately assess and enhance image quality, achieving a 98% accuracy in quality control. By improving image clarity, it optimizes the diagnostic process. The solution also supports AI-driven segmentation, detection, and quantitative analysis of images, automating tasks and reducing the rate of missed diagnoses. With diagnosis times cut by 40%, healthcare providers see a significant boost in efficiency.

For ultrasound applications, this system integrates digital imaging devices powered by OpenHarmony, utilizing an AI device-edge synergy framework. This architecture allows for real-time AI-assisted diagnosis with low latency video transmission, enabling centralized quality control across regions. Instead of relying on occasional spot checks, ultrasound quality control can now cover the entire region. The AI-assisted diagnosis process maintains an end-to-end delay of less than 150 milliseconds, ensuring continuous improvements in diagnostic quality and efficiency throughout the area.

Li Junfeng, Huawei’s Vice President and President of the Global Public Sector, highlighted that the coming years present significant opportunities for digital and intelligent technologies to drive healthcare's growth. Huawei is committed to foundational technologies and is constantly advancing its solutions tailored to the healthcare sector, including Smart Wards, Smart Hospital Campuses, and Telemedicine. So far, Huawei has supported over 5,000 healthcare facilities across more than 110 countries and regions worldwide.